...
首页> 外文期刊>Artificial Organs >Effectiveness of Combining Plasma Exchange With Continuous Hemodiafiltration on Acute Fatty Liver of Pregnancy Complicated by Multiple Organ Dysfunction
【24h】

Effectiveness of Combining Plasma Exchange With Continuous Hemodiafiltration on Acute Fatty Liver of Pregnancy Complicated by Multiple Organ Dysfunction

机译:血浆置换与持续血液透析滤过相结合对急性脂肪肝并发多器官功能障碍的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Acute fatty liver of pregnancy (AFLP) is a rare disease of progressive hepatic insufficiency and secondary systemic complications that induce significant maternal risk. The application of combining plasma exchange (PE) and continuous hemodiafiltration (CHDF) is a novel concept for patients with AFLP. Since 2002, we have utilized the combination of PE with CHDF as adjunctive medical therapy for 11 AFLP patients with multiple organ dysfunction. Before PE and CHDF initiation, four patients had signs and symptoms of encephalopathy, four required ventilatory support, and all 11 were developing liver failure, significant renal compromise, and coagulopathy. PE combined with CHDF for patients was initiated a mean of 2days postpartum (range, days 0-3). Daily or every other day PE combined with CHDF was undertaken on two to eight occasions for each of the 11 patients. Ten patients responded with composite clinical and laboratory improvement and were discharged to the ward, then cured and discharged from hospital; one patient died of septic shock. Average duration of hospitalization was 17days (range, days 9-38) from time of admission to discharge; the average duration of intensive care unit was 10days (range, days 4-23). No significant PE- and CHDF-related complications occurred. These results indicate that combing PE and CHDF in a series-parallel circuit is an effective and safe treatment for patients with severe AFLP. This finding may have important implications for the development of an effective treatment for patients with AFLP suffering multiple organ dysfunction.
机译:妊娠急性脂肪肝(AFLP)是一种罕见的进行性肝功能不全和继发性系统性并发症,会引起巨大的产妇风险。血浆置换(PE)和连续血液透析滤过(CHDF)相结合的应用是AFLP患者的新概念。自2002年以来,我们将PE与CHDF的结合作为辅助药物治疗11例多器官功能障碍的AFLP患者。在开始PE和CHDF之前,四名患者出现脑病的体征和症状,四名需要通气支持,所有11名患者均出现肝衰竭,严重的肾功能不全和凝血病。 PE联合CHDF的患者平均在产后2天(范围0-3天)开始。每天或隔天对11例患者进行2至8次PE联合CHDF治疗。十名患者在临床和实验室方面得到了综合改善,并出院,然后治愈并出院。一名患者死于败血性休克。从入院到出院,平均住院时间为17天(范围为9-38天);重症监护病房的平均病程为10天(范围为4-23天)。没有发生与PE和CHDF相关的重大并发症。这些结果表明,将PE和CHDF串联串联组合治疗对于严重AFLP患者是一种有效而安全的治疗方法。该发现可能对开发患有多器官功能障碍的AFLP患者的有效治疗方法具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号